Guide Therapeutics
Tucker
About Guide Therapeutics
Guide Therapeutics is a biotechnology company that solves the challenge of delivery of genetic therapies. The company patented technologies to test thousands of chemically distinct nanoparticles in vivo. This enables them to identify simple, scalable, and clinically relevant nanoparticles that target new cell types efficiently and safely. It pioneers new gene therapies by developing field-leading drug delivery vehicles. Guide Therapeutics is using a proprietary screening platform that performs thousands of drug delivery experiments directly in vivo, they identify nanoparticles that deliver DNA or RNA to cell types others cannot reach.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: M&A
- Last round: Series Unknown (Aug 2020)
- Website: guidetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/guide-therapeutics-176914 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.